awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26740233-2A070BE0-9809-4348-A225-714D2FF48DD2
Q26740233-2A070BE0-9809-4348-A225-714D2FF48DD2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26740233-2A070BE0-9809-4348-A225-714D2FF48DD2
Spotlight on grazoprevir-elbasvir once-daily combination and its potential in the treatment of hepatitis C
P2860
Q26740233-2A070BE0-9809-4348-A225-714D2FF48DD2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26740233-2A070BE0-9809-4348-A225-714D2FF48DD2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
18d022f0b6b562d65f48fb1d17cf4656f05ca7cb
P2860
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a